Trial Outcomes & Findings for Fresh Food Farmacy: A Randomized Controlled Trial (NCT NCT03718832)

NCT ID: NCT03718832

Last Updated: 2025-06-12

Results Overview

Glycated hemoglobin (HbA1c) is a measure of the average share of glucose that has been in the bloodstream over the 2-3 months preceding measurement. HbA1c is measured by performing assays on samples of the participants' blood. Units are percentages; for differences between HbA1c values, units are percentage points. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

500 participants

Primary outcome timeframe

6 months after trial enrollment

Results posted on

2025-06-12

Participant Flow

Participant milestones

Participant milestones
Measure
Treatment Group-Begin Now
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Analysis Sample
STARTED
249
251
Analysis Sample
COMPLETED
230
235
Analysis Sample
NOT COMPLETED
19
16
6-month HbA1c Sample
STARTED
230
235
6-month HbA1c Sample
COMPLETED
170
179
6-month HbA1c Sample
NOT COMPLETED
60
56

Reasons for withdrawal

Reasons for withdrawal
Measure
Treatment Group-Begin Now
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Analysis Sample
Withdrawal by Subject
18
15
Analysis Sample
Legal hold on data
1
0
Analysis Sample
Participant from treated household
0
1
6-month HbA1c Sample
Lost to Follow-up
60
56

Baseline Characteristics

Fresh Food Farmacy: A Randomized Controlled Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Total
n=465 Participants
Total of all reporting groups
Age, Continuous
54.8 years
STANDARD_DEVIATION 11.3 • n=99 Participants
54.4 years
STANDARD_DEVIATION 12.4 • n=107 Participants
54.6 years
STANDARD_DEVIATION 11.8 • n=206 Participants
Sex: Female, Male
Female
130 Participants
n=99 Participants
125 Participants
n=107 Participants
255 Participants
n=206 Participants
Sex: Female, Male
Male
100 Participants
n=99 Participants
110 Participants
n=107 Participants
210 Participants
n=206 Participants
Race/Ethnicity, Customized
Hispanic (any race)
16 Participants
n=99 Participants
23 Participants
n=107 Participants
39 Participants
n=206 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
23 Participants
n=99 Participants
18 Participants
n=107 Participants
41 Participants
n=206 Participants
Race/Ethnicity, Customized
Non-Hispanic White
189 Participants
n=99 Participants
189 Participants
n=107 Participants
378 Participants
n=206 Participants
Race/Ethnicity, Customized
Non-Hispanic and other race
2 Participants
n=99 Participants
5 Participants
n=107 Participants
7 Participants
n=206 Participants
Region of Enrollment
United States
230 Participants
n=99 Participants
235 Participants
n=107 Participants
465 Participants
n=206 Participants
Prior-year healthcare use
Any inpatient admission
59 Participants
n=99 Participants
48 Participants
n=107 Participants
107 Participants
n=206 Participants
Prior-year healthcare use
Any emergency department visit
97 Participants
n=99 Participants
94 Participants
n=107 Participants
191 Participants
n=206 Participants
Clinic location
Rural
64 Participants
n=99 Participants
67 Participants
n=107 Participants
131 Participants
n=206 Participants
Clinic location
Urban
166 Participants
n=99 Participants
168 Participants
n=107 Participants
334 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 6 months after trial enrollment

Population: Participants from the 465-person analysis sample who completed an HbA1c blood test between 5 and 10 months after program enrollment.

Glycated hemoglobin (HbA1c) is a measure of the average share of glucose that has been in the bloodstream over the 2-3 months preceding measurement. HbA1c is measured by performing assays on samples of the participants' blood. Units are percentages; for differences between HbA1c values, units are percentage points. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=170 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=179 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
HbA1c
8.781177 % of hemoglobin
Standard Deviation 1.643995
8.814526 % of hemoglobin
Standard Deviation 1.978937

SECONDARY outcome

Timeframe: 12 months after trial enrollment

Glycated hemoglobin. Units are percentages (for differences, percentage points) reflecting the average share of glucose in the bloodstream over the previous 2-3 months. An HbA1c value of 6.5% is the lower threshold for type 2 diabetes. HbA1c values are rarely above 15-20%. In the context of this study (patients with type 2 diabetes), higher scores are considered a worse outcome.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
HbA1c
8.735975 % of hemoglobin
Standard Deviation 1.748229
8.595031 % of hemoglobin
Standard Deviation 2.035983

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who completed blood tests between 6 and 12 months after trial enrollment.

Fasting blood glucose is a measure of blood sugar control over a short time period (the blood glucose content after an overnight fast). Units are mg/dL. To convert to mmol/L (SI), multiply by 0.0113. Lower fasting blood glucose levels indicate better health within the context of this study.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=127 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=137 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Fasting Glucose
6 months after trial enrollment
185.0236 mg/dL
Standard Deviation 76.36467
198.292 mg/dL
Standard Deviation 99.97935
Fasting Glucose
12 months after trial enrollment
185.4696 mg/dL
Standard Deviation 68.86821
172.3441 mg/dL
Standard Deviation 68.18301

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who had their weight recorded between 6 and 12 months after trial enrollment.

Weight in pounds. In the context of this study, higher values are considered a worse outcome. SI conversion factor: To convert pounds to kilograms, multiply by 0.4536.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=195 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=205 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Weight (lb)
6 months after trial enrollment
230.8205 pounds (lb)
Standard Deviation 60.13527
238.9561 pounds (lb)
Standard Deviation 66.3286
Weight (lb)
12 months after trial enrollment
227.9171 pounds (lb)
Standard Deviation 58.1217
237.5989 pounds (lb)
Standard Deviation 63.47953

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants whose weight was recorded between 6 and 12 months after trial enrollment.

Body Mass Index (BMI) in kg/m\^2. BMI is computed using weight (lb) and height (in). The CDC's healthy reference range for BMI among adults aged 20 and older is 18.5 to 24.9. BMI values greater than or equal to 30.0 indicate obesity. In the context of this study, higher BMI is considered a worse outcome.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=195 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=205 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Body Mass Index
6 months after trial enrollment
36.77117 kg/m^2
Standard Deviation 8.615884
37.6461 kg/m^2
Standard Deviation 10.06821
Body Mass Index
12 months after trial enrollment
36.20175 kg/m^2
Standard Deviation 8.299285
37.65195 kg/m^2
Standard Deviation 9.895644

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.

Total cholesterol in mg/dL. The CDC recommends total cholesterol levels around 150 mg/dL and classifies levels of 200 mg/dL and above as unhealthy (hyperlipidemia). In the context of this study, higher total cholesterol indicates a worse outcome. SI conversion factor: To convert from mg/dL to mmol/L, multiply by 0.0259.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Total Cholesterol
6 months after trial enrollment
170.3087 mg/dL
Standard Deviation 55.49542
160.5404 mg/dL
Standard Deviation 48.39021
Total Cholesterol
12 months after trial enrollment
164.8345 mg/dL
Standard Deviation 50.04346
165.3806 mg/dL
Standard Deviation 56.96481

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.

Low-density lipoprotein (LDL) cholesterol, measured in mg/dL. The CDC recommends LDL levels of 100 mg/dL or below. In the context of this study, higher levels of LDL indicate a worse outcome. SI conversion factor: To convert from mg/dL to mmol/L, multiply by 0.0259.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=151 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=158 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
LDL Cholesterol
6 months after trial enrollment
93.54835 mg/dL
Standard Deviation 44.67019
85.19621 mg/dL
Standard Deviation 36.72769
LDL Cholesterol
12 months after trial enrollment
87.36268 mg/dL
Standard Deviation 36.73616
84.72519 mg/dL
Standard Deviation 36.62367

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.

High-density lipoprotein (HDL) cholesterol, measured in mg/dL. The CDC recommends HDL levels of at least 40 mg/dL in men and 50 mg/dL in women. In the context of this study, higher levels of HDL indicate a better outcome. SI conversion factor: To convert mg/dL to mmol/L, multiply by 0.0259.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=161 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
HDL Cholesterol
6 months after trial enrollment
41.27718 mg/dL
Standard Deviation 12.98269
41.8323 mg/dL
Standard Deviation 12.08006
HDL Cholesterol
12 months after trial enrollment
42.34722 mg/dL
Standard Deviation 12.73743
43.73333 mg/dL
Standard Deviation 17.07761

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who completed blood tests including cholesterol measurements between 6 and 12 months after trial enrollment.

Triglycerides, measured in mg/dL. The CDC recommends levels of triglycerides below 150 mg/dL. In the context of this study, higher levels of triglycerides indicate worse outcomes. SI conversion factor: To convert mg/dL to mmol/L, multiply by 0.0113.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=149 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=162 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Triglycerides
6 months after trial enrollment
223.5705 mg/dL
Standard Deviation 155.5674
201.0123 mg/dL
Standard Deviation 157.1144
Triglycerides
12 months after trial enrollment
212.7762 mg/dL
Standard Deviation 153.4214
224.1288 mg/dL
Standard Deviation 268.9378

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who had their blood pressure recorded between 6 and 12 months after trial enrollment.

Systolic blood pressure, measured in mm Hg. The CDC identifies normal healthy systolic blood pressure as below 120 mm Hg. The American College of Cardiology identifies 120 to 129 mm Hg as elevated blood pressure and 130 mm Hg and higher as hypertensive. Higher systolic blood pressure levels indicate worse outcomes.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=186 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=192 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Systolic Blood Pressure
6 months after trial enrollment
128.3118 mm Hg
Standard Deviation 19.06545
130.1823 mm Hg
Standard Deviation 20.29064
Systolic Blood Pressure
12 months after trial enrollment
126.0235 mm Hg
Standard Deviation 17.24071
129.7956 mm Hg
Standard Deviation 18.45165

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in the number of participants who had their blood pressure recorded between 6 and 12 months after trial enrollment.

Diastolic blood pressure, measured in mm Hg. The American College of Cardiology identifies normal diastolic blood pressure as below 80 mm Hg and elevated/hypertensive diastolic blood pressure as 80 mm Hg or above. Higher levels of diastolic blood pressure indicate worse outcomes.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=186 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=192 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Diastolic Blood Pressure
6 months after trial enrollment
74.2043 mm Hg
Standard Deviation 10.71504
74.76041 mm Hg
Standard Deviation 10.40413
Diastolic Blood Pressure
12 months after trial enrollment
74.48235 mm Hg
Standard Deviation 9.271847
73.98343 mm Hg
Standard Deviation 10.46395

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate fruit.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=163 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Times Eating Fruit in the Past 7 Days
6 months after trial enrollment
5.564417 # times
Standard Deviation 3.344494
5.241177 # times
Standard Deviation 3.397799
Times Eating Fruit in the Past 7 Days
12 months after trial enrollment
5.097222 # times
Standard Deviation 2.377986
5.79562 # times
Standard Deviation 3.343428

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate dark green vegetables.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=163 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Times Eating Dark Green Vegetables in the Past 7 Days
6 months after trial enrollment
6.288343 # times
Standard Deviation 20.69643
4.011765 # times
Standard Deviation 2.9007
Times Eating Dark Green Vegetables in the Past 7 Days
12 months after trial enrollment
4.202797 # times
Standard Deviation 2.378186
5.782609 # times
Standard Deviation 8.36899

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient drank sweetened beverages.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=162 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=167 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Times Drinking Sweetened Beverages in the Past 7 Days
6 months after trial enrollment
2.777778 # times
Standard Deviation 3.449728
3.407186 # times
Standard Deviation 4.495186
Times Drinking Sweetened Beverages in the Past 7 Days
12 months after trial enrollment
2.377622 # times
Standard Deviation 3.116978
2.550725 # times
Standard Deviation 3.60266

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Patient-reported measure of diet improvement: Number of times in the last 7 days when the patient ate fast food, takeout, or at a restaurant.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Times Eating Out in the Past 7 Days
6 months after trial enrollment
4.5 # times
Standard Deviation 3.948285
4.017544 # times
Standard Deviation 3.78771
Times Eating Out in the Past 7 Days
12 months after trial enrollment
4.402778 # times
Standard Deviation 3.956617
4.413043 # times
Standard Deviation 3.927682

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Patient-reported measure of diet improvement: Survey question: "Do you believe your diet has improved compared to one year ago?".

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Participants Answering "Yes" for Diet Improvement Compared to One Year Ago
6 months after trial enrollment
153 Participants
132 Participants
Participants Answering "Yes" for Diet Improvement Compared to One Year Ago
12 months after trial enrollment
137 Participants
129 Participants

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

The proportion of questions testing patients' knowledge of how different factors contribute to blood sugar answered correctly.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=160 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=170 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Mean Proportion of Diabetes Knowledge Questions Answered Correctly
6 months after trial enrollment
0.8267857 proportion of questions
Standard Deviation 0.1489169
0.7756302 proportion of questions
Standard Deviation 0.1472909
Mean Proportion of Diabetes Knowledge Questions Answered Correctly
12 months after trial enrollment
0.8271728 proportion of questions
Standard Deviation 0.1416987
0.8133472 proportion of questions
Standard Deviation 0.1444886

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed differs due to differences in survey (non)response between surveys completed at 6 and 12 months after trial enrollment.

Survey-based index score for patient-reported positive engagement outcomes. Scores range from 0 to 1. Scores are standardized so that the control group always has a mean score of 0 and standard deviation of 1. Higher scores reflect better outcomes---here, better engagement with the program. Scores composite results from multiple survey questions while adjusting for covariance between questions.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=164 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=171 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Engagement Index Score
6 months after trial enrollment
0.4018523 score on a scale
Standard Deviation 0.8282961
0 score on a scale
Standard Deviation 1
Engagement Index Score
12 months after trial enrollment
0.000623 score on a scale
Standard Deviation 0.8280342
0 score on a scale
Standard Deviation 1

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

Healthcare utilization: Number of outpatient claims among continuously enrolled/insured subjects during the relevant time frame after trial enrollment.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Outpatient Visits Claimed by Insurance
6 months after trial enrollment
5.765217 Number of claims
Standard Deviation 4.884394
4.86383 Number of claims
Standard Deviation 4.628804
Number of Outpatient Visits Claimed by Insurance
12 months after trial enrollment
10.1 Number of claims
Standard Deviation 8.088674
10.07234 Number of claims
Standard Deviation 8.314793

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

Healthcare utilization: Number of inpatient and emergency department claims among continuously enrolled/insured subjects during the relevant time frame after enrollment.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Inpatient and Emergency Department Visits Claimed by Insurance
6 months after trial enrollment
0.6869565 Number of claims
Standard Deviation 1.363051
0.7914894 Number of claims
Standard Deviation 1.680434
Number of Inpatient and Emergency Department Visits Claimed by Insurance
12 months after trial enrollment
1.221739 Number of claims
Standard Deviation 2.116365
1.497872 Number of claims
Standard Deviation 3.350436

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

The number of subjects who were continuously enrolled/insured who had any outpatient claims during the relevant time frame after trial enrollment. For statistical analyses, coefficients and errors represent proportions of participants, relative to the size of the group/treatment arm.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Proportion of Participants Filing Outpatient Insurance Claims With Insurance
6 months after trial enrollment
215 Participants
207 Participants
Proportion of Participants Filing Outpatient Insurance Claims With Insurance
12 months after trial enrollment
221 Participants
224 Participants

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

The number of subjects who were continuously enrolled/insured who had any inpatient or emergency department claims during the relevant time frame after trial enrollment. For statistical analyses, coefficients and errors represent proportions of participants, relative to the size of the group/treatment arm.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Proportion of Participants Filing Inpatient or Emergency Department Claims With Insurance
6 months after trial enrollment
70 Participants
84 Participants
Proportion of Participants Filing Inpatient or Emergency Department Claims With Insurance
12 months after trial enrollment
96 Participants
110 Participants

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

Healthcare utilization: Total value (USD) of inpatient and emergency department payments among continuously enrolled/insured subjects during the relevant time frame after enrollment.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=105 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=96 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Inpatient and Emergency Department Payments
6 months after trial enrollment
2175.39 USD
Standard Deviation 6176.236
2161.593 USD
Standard Deviation 5284.944
Inpatient and Emergency Department Payments
12 months after trial enrollment
3284.667 USD
Standard Deviation 7850.193
4545.119 USD
Standard Deviation 9951.439

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

Population: Number of participants analyzed may differ due to differences in the number of participants who remained continuously enrolled in the health plan between 6 and 12 months after trial enrollment.

Healthcare utilization: Value (USD) of outpatient payments among continuously enrolled/insured subjects during the relevant time frame after enrollment.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=105 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=96 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Outpatient Payments
6 months after trial enrollment
3313.627 USD
Standard Deviation 6553.01
2023.022 USD
Standard Deviation 3492.728
Outpatient Payments
12 months after trial enrollment
5327.305 USD
Standard Deviation 7561.854
4117.954 USD
Standard Deviation 5205.939

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

The number of times an individual participant completed a medical appointment with a dietician in the relevant time frame, based on electronic health records.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Visits to a Dietician
6 months after trial enrollment
2.656522 number of visits
Standard Deviation 1.745694
0.6212766 number of visits
Standard Deviation 1.263041
Number of Visits to a Dietician
12 months after trial enrollment
4.53913 number of visits
Standard Deviation 3.029079
2.919149 number of visits
Standard Deviation 2.701269

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

The number of times an individual participant completed a Diabetes Self-Management Training (DSMT) in the relevant time frame, based on electronic health records.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Diabetes Self-Management Trainings Completed
6 months after trial enrollment
2.243478 number of trainings
Standard Deviation 1.439258
0.3617021 number of trainings
Standard Deviation 0.7168763
Number of Diabetes Self-Management Trainings Completed
12 months after trial enrollment
3.791304 number of trainings
Standard Deviation 2.498893
2.140425 number of trainings
Standard Deviation 1.888297

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

The number of times an individual participant completed a medical appointment with an endocrinologist in the relevant time frame, based on electronic health records.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Visits to an Endocrinologist
6 months after trial enrollment
0.5913044 number of appointments
Standard Deviation 0.8605437
0.4808511 number of appointments
Standard Deviation 0.7970668
Number of Visits to an Endocrinologist
12 months after trial enrollment
1.095652 number of appointments
Standard Deviation 1.468588
0.8893617 number of appointments
Standard Deviation 1.302731

SECONDARY outcome

Timeframe: 6 and 12 months after trial enrollment

The number of times an individual participant completed a medical appointment regarding weight loss or weight management in the relevant time frame, based on electronic health records.

Outcome measures

Outcome measures
Measure
Treatment Group-Begin Now
n=230 Participants
Group 1- Will be randomized to the treatment ("Begin Now") group for the Fresh Food Farmacy program. Subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program right away when the program opens in their geographic area. Data will be collected during the first 12 months of subject participation and EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total). Fresh Food Farmacy: Patients are prescribed fresh food by a dietician, fill the prescription each week at the FFF clinic, receive training on how to use the food, and training in diabetes self management.
Control Group-Begin Later
n=235 Participants
Group 2- Will be randomized to the control ("Begin Later") group for the FFF program. These subjects will be consented to join the FFF study prior to learning their program start date. They will join the FFF program approximately 6 months after the program opens in their geographic area. Data will be collected during the first 6 months of subject participation and used as control data for the study. EHR and claims data may be analyzed for an additional 12 month follow-up period (24 months in total from the start of the trial).
Number of Weight Loss and Weight Management Appointments Completed
6 months after trial enrollment
0.0521739 number of appointments
Standard Error 0.3457409
0.1106383 number of appointments
Standard Error 0.5193825
Number of Weight Loss and Weight Management Appointments Completed
12 months after trial enrollment
0.0521739 number of appointments
Standard Error 0.3457409
0.2212766 number of appointments
Standard Error 0.9707113

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Healthy behaviors observed in electronic health record, including preventive care and appointments kept

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Healthy behaviors observed in paid claims using Healthcare Effectiveness Data and Information Set (HEDIS) measures. These measures were not collected for this study.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

HbA1c available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Weight in pounds as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

BMI in kg/m\^2 in pounds as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Cholesterol as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Blood pressure as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Triglycerides as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Fasting glucose as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Inpatient utilization for household members as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Outpatient utilization for household members as available in EHR records

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Inpatient utilization for household members as available in paid claims

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Outpatient utilization for household members as available in paid claims

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Separate results by tercile of baseline HbA1c

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Heterogeneity analysis by site of the clinic

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months and 12 months

Heterogeneity analysis by causal trees using the baseline characteristics to explore heterogeneity, sample size permitting.

Outcome measures

Outcome data not reported

Adverse Events

Treatment Group-Begin Now

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group-Begin Later

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Joseph doyle

MIT Sloan School of Management

Phone: 6174523761

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place